LDHA and breast carcinoma: For instance, ALDH+ breast cancer cells were reported to be more tumorigenic, metastatic, invasive, and migratory compared to ALDH− breast cancer cells and were associated with poor clinical outcomes and decreased patient survival [29, 30].